Study Spotlights Efficacy Of Questionnaire To Identify Patients At High Risk For Lung Cancer
Posted on: Sunday, 1 November 2009, 14:49 CST
Asking a few questions can help determine risk for lung cancer
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001, the current study confirmed 18 cases of cancer of the original 430 patients who qualified as high risk after completing a five-minute questionnaire.
The study was conducted in primary care physician offices among patients seeking care for general health issues. The evaluating physician incorporated a simple questionnaire focused in three areas: risks, environments and genetics. Specific questions included smoking habit, occupational environments (mining, construction or railroad),subsequent exposure to chemicals and family history.
Colorado's Primary Care Partners surveyed more than 1,000 patients to evaluate their corresponding risk of lung cancer. Almost half of those surveyed qualified as high risk, and 126 of these identified underwent spinometry, a non-invasive breath measurement procedure. Of the patients with airflow obstruction, 88 underwent a full lung cancer screening. After five years, the study confirmed lung cancer in eight patients with obstructed airflow and 10 in of the patients without.
The study opened the door to mitigate late diagnosis through embedding these simple questions into the patient-physician dialogue. "Simple by design, our initiative received widespread community support from physicians, patients and hospitals," said lead investigator Thomas Petty, MD. By providing the guidelines for pointed questions when patients are face-to-face with physicians, we can begin to identify those at risk."
---
On the Net:
Related Articles
- Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
- ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients With Advanced Endometrial Cancer
- Patients Dealing with Rising Cancer Treatment Costs
- Avantogen Oncology Inc. Announces Preliminary Results of a Dose Ranging Study of RP101 in Combination With Gemcitabine Chemotherapy in Patients With Advanced Pancreatic Cancer
- AmpliMed Initiates Phase I Clinical Study of Benzimate in Patients With Advanced Refractory Cancer
- Medical Management Shifts Focus to High-Risk Patients, URAC Study Finds
- Answering Three Simple Questions Could Improve Asthma Control for Millions of Patients and Save Lives
- OvaRex MAb for Patients With Advanced Ovarian Cancer May Extend Remission Following Favorable Surgery and Chemotherapy
- Primary Care Providers' Attitudes Toward Prostate Cancer Risk Factors at a Veterans Affairs Health Care Facility
 |
 |
User Comments (0)
RSS Feeds